Baystate Wealth Management’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
$194 Hold
9
﹤0.01% 1268
2023
Q3
$167 Hold
9
﹤0.01% 989
2023
Q2
$228 Sell
9
-50
-85% -$1.26K ﹤0.01% 1006
2023
Q1
$1.53K Buy
59
+6
+11% +$161 ﹤0.01% 877
2022
Q4
$1K Hold
53
﹤0.01% 912
2022
Q3
$1K Hold
53
﹤0.01% 858
2022
Q2
$2K Hold
53
﹤0.01% 788
2022
Q1
$4K Hold
53
﹤0.01% 692
2021
Q4
$5K Hold
53
﹤0.01% 657
2021
Q3
$7K Hold
53
﹤0.01% 570
2021
Q2
$9K Hold
53
﹤0.01% 519
2021
Q1
$10K Buy
53
+38
+253% +$8.81K ﹤0.01% 464
2020
Q4
$3K Buy
+15
New +$3.05K ﹤0.01% 545

Other funds holding TDOC

Baystate Wealth Management's TDOC Position: Q4 2023 in Review

Baystate Wealth Management held its Teladoc Health (TDOC) position steady in Q4 2023 at 9 shares worth $194. The position accounts for ﹤0.01% of the portfolio, ranked #1268.

Baystate Wealth Management first reported a position in TDOC in Q4 2020 and has held it in 13 quarters since. The position peaked at $10K in Q1 2021. 435 funds tracked by Wall St. Rank hold TDOC as of Q4 2023.

  • Baystate Wealth Management held 9 shares of Teladoc Health worth $194 as of Q4 2023.
  • Baystate Wealth Management left its Teladoc Health share count unchanged in Q4 2023.
  • Teladoc Health made up ﹤0.01% of Baystate Wealth Management's portfolio in Q4 2023, its #1268 holding.
  • Baystate Wealth Management first reported a position in Teladoc Health in Q4 2020 and has held it in 13 quarters since.
  • Baystate Wealth Management's Teladoc Health position peaked at $10K in Q1 2021.
  • 435 funds tracked by Wall St. Rank held Teladoc Health as of Q4 2023.

Based on Baystate Wealth Management's 13F filing for Q4 2023, filed 29 Jan 2024.